Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 22 | N/A |
| TOTAL | $22 | $N/A |
| Non-Current Assets | ||
| TOTAL | $N/A | $N/A |
| Total Assets | $22 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 3 | 0 |
| TOTAL | $3 | $N/A |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $3 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 1 | N/A |
| Retained earnings | -1,474 | N/A |
| TOTAL | $19 | $N/A |
| Total Liabilities And Equity | $22 | $0 |